FDA DEVICE FACTS
USTAR II System
United Orthopedic Corporation
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
USTAR II Knee System Metastatic tumor (i.e. osteosarcoma, chondrosarcoma, giant cell tumor or osteoma) where massive resection and transplantation are needed. Severe knee joint damage resulting fro m trauma where massive resection and transplantation are needed. Non-inflammatory degenerative joint disease such as avascular necrosis, osteoarthritis, or traumatic arthritis. Revision of previously failed total joint arthroplasty, osteotomy, or arthrodesis. Joint instability resulting from excessive bone resection. For Femoral component, Hinged/ Tibial baseplate, Hinged/ Cemented tibial stem/ Cemented Straight stem, RHS, non coated/ Cemented Curved stem, RHS, non coated/ Cemented Straight stem, RHS/ Cemented Curved stem, RHS/ Tibial Augment: These devices are single use implant and intended for cemented use only. For Distal Femoral Component, RHS/ Proximal Tibial Component, RHS/ Tibial stem/ Segment Part, RHS/ Segment Part, RHS, Bridge: These devices are single use implant and intended for cementless use only. USTAR II Knee System, Stem Metastatic tumor (i.e. osteosarcoma, chondrosarcoma, giant cell tumor or osteoma) resulting from trauma where massive resection and transplantation are needed. Severe knee joint damage resulting fro m trauma where massive resection and transplantation are needed. Non-inflammatory degenerative joint disease such as avascular necrosis, osteoarthritis, or traumatic arthritis. Correction for revision of unsuccessful osteotomy, arthrodesis, or failure of previous joint replacement. Joint instability resulting from excessive bone resection. Cemented Tibial Stem is a single use implant and intended for cemented use only. Tibial Stem is a single use implant and intended for cementless use only. USTAR II Hip System Metastatic tumor (i.e. osteosarcoma, chondrosa rcoma, giant cell tumor or osteoma) where massive resection and transplantation are needed. Severe knee joint damage resulting fro m trauma where massive resection and transplantation are needed. Non-inflammatory degenerative joint disease such as avascular necrosis, osteoarthritis, or traumatic arthritis. Revision of previously failed total joint arthroplasty, osteotomy, or arthrodesis. Joint instability resulting from excessive bone resection. This device is a single use implant and intended for uncemented use only. Comparison of Technological Characteristics with the Predicate Device: The features of the subject device are compar able to the predicates mention ed above in terms of the indication for use, design rationale, materials, coating and sterilization method. The differences have been validated by several testing to demonstrate that the performance of subject device is substantially equivalent to that of the predicate devices.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。